{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-006118","form_type":"8-K","ticker":"ATAI","cik":"0002081043","company_name":"AtaiBeckley Inc.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.203586+00:00","generated_at":"2026-05-16T01:51:20.446083+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AtaiBeckley appoints Michael Faerm CFO effective March 9, 2026; Johnson becomes CAO","bullets":["Michael Faerm appointed CFO of AtaiBeckley, effective March 9, 2026; Anne Johnson becomes Chief Accounting Officer.","Faerm receives $525k base salary, 40% target bonus, option for 1.275M shares, 285k RSUs (4-yr vest), and $85k sign-on bonus.","Severance: 0.75x salary for 9 months; change-in-control: lump sum salary+target bonus plus accelerated equity vesting.","Faerm previously CFO at Viracta Therapeutics, interim CFO at Harpoon Therapeutics, and CFO at Artiva Biotherapeutics.","CEO cites Faerm's experience as BPL-003 nears Phase 3 and other clinical-stage programs advance."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-006118","json":"https://secwatch.observer/filing/0001140361-26-006118.json","markdown":"https://secwatch.observer/filing/0001140361-26-006118.md","text":"https://secwatch.observer/filing/0001140361-26-006118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126006118/0001140361-26-006118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126006118/ef20066047_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:51:20.446083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}